Desmogleins as Prognostic Biomarkers in Resected Pancreatic Ductal Adenocarcinoma

British Journal of Cancer - United Kingdom
doi 10.1038/bjc.2015.362
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Prognostic Significance of XB130 Expression in Surgically Resected Pancreatic Ductal Adenocarcinoma

World Journal of Surgical Oncology
SurgeryOncology
2014English

Ploidy and DNA Index as Prognostic Factors in Resected Pancreatic Ductal Adenocarcinoma – A Review of the Literature

Przeglad Gastroenterologiczny
Gastroenterology
2014English

Cytokines as Biomarkers of Pancreatic Ductal Adenocarcinoma: A Systematic Review

PLoS ONE
Multidisciplinary
2016English

Fibrosis-Related miRNAs as Serum Biomarkers for Pancreatic Ductal Adenocarcinoma

Oncotarget
Oncology
2017English

Prognostic Significance of Maspin in Pancreatic Ductal Adenocarcinoma: Tissue Microarray Analysis of 223 Surgically Resected Cases

Modern Pathology
Forensic MedicinePathology
2007English

Five Key lncRNAs Considered as Prognostic Targets for Predicting Pancreatic Ductal Adenocarcinoma

Journal of Cellular Biochemistry
BiochemistryCell BiologyMolecular Biology
2018English

Prognostic Significance of PINCH Signalling in Human Pancreatic Ductal Adenocarcinoma

HPB
HepatologyGastroenterology
2010English

Role of the Lymph Node Ratio as the Prognostic Factor for Resected Pancreatic Ductal Carcinoma

HPB
HepatologyGastroenterology
2016English

Is Hyaluronan Deposition in the Stroma of Pancreatic Ductal Adenocarcinoma of Prognostic Significance?

PLoS ONE
Multidisciplinary
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy